Fennec Pharmaceuticals Inc.
FENC
NASDAQ·Healthcare·Biotechnology·Mkt cap $430.4M
$12.39
▼ -1.27%
P/E
-95.31
Mkt Cap
$430.4M
52-Wk Range
$5.65–$13.25
52-Week Range
$5.65 - $13.25
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Up 37.4% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
4 reasons
- First-mover advantage in platinum-induced ototoxicity prevention
- Proprietary formulation technology for sodium thiosulfate delivery
- Regulatory designations and pediatric development incentives
- Focused therapeutic niche with limited competitive landscape
Bear Case
2 risks
- Average volatility.
- Significant premium - growth priced in
Growth
Turning profitable
PEDMARK regulatory approval and market launch
Value
Significant premium - growth priced in
Momentum
Hot
+39.2% over 3m
Quality
Excellent
Strong fundamentals
Dividend
None
No dividend
Smart-money signal
Who's buying FENC right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Latest print - beat on both lines
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Nov 5, 2026
AUG 11, 2026
Reported EPS of $0.05 vs $0.02 consensus (+150.0% surprise). Revenue of $17.9M vs $16.2M expected (+10.3%). Beat on both top and bottom lines.
EPS surprise · last 4Q
1 of 1 beats
Estimate
Actual
Q3 26
+150.0%
Revenue trend · last 8Q
—
—
-66%
+33%
+79%
+77%
+73%
+85%
Q3 24
Q4 24
Q1 25
Q2 25
Q3 25
Q4 25
Q1 26
Q2 26
$7.0M
$7.9M
$8.8M
$9.7M
$12.5M
$14.0M
$15.1M
$17.9M
Margins · last 8Q
Gross
96.0%
Operating
9.7%
Profit
11.0%
Wall Street consensus
3 analysts · 100% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
100%
Hold
0%
Sell
0%
Median Price Target
—
Latest: B. Riley · Aug 12, 2026
vs Industry
How FENC stacks vs Biotechnology
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.
Related